252 related articles for article (PubMed ID: 1828371)
1. Single-chain urokinase-type plasminogen activator does not possess measurable intrinsic amidolytic or plasminogen activator activities.
Husain SS
Biochemistry; 1991 Jun; 30(23):5797-805. PubMed ID: 1828371
[TBL] [Abstract][Full Text] [Related]
2. Activation of plasminogen by single-chain urokinase or by two-chain urokinase--a demonstration that single-chain urokinase has a low catalytic activity (pro-urokinase).
Pannell R; Gurewich V
Blood; 1987 Jan; 69(1):22-6. PubMed ID: 3790724
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional characterization of mutants of recombinant single-chain urokinase-type plasminogen activator obtained by site-specific mutagenesis of Lys158, Ile159 and Ile160.
Lijnen HR; Nelles L; Van Hoef B; Demarsin E; Collen D
Eur J Biochem; 1988 Nov; 177(3):575-82. PubMed ID: 2973984
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the intrinsic fibrinolytic properties of pro-urokinase through a study of plasmin-resistant mutant forms produced by site-specific mutagenesis of lysine(158).
Gurewich V; Pannell R; Broeze RJ; Mao J
J Clin Invest; 1988 Dec; 82(6):1956-62. PubMed ID: 2974047
[TBL] [Abstract][Full Text] [Related]
5. Keratinocyte urokinase-type plasminogen activator is secreted as a single chain precursor.
Hashimoto K; Prystowsky JH; Baird J; Lazarus GS; Jensen PJ
J Invest Dermatol; 1988 Jun; 90(6):823-8. PubMed ID: 2967334
[TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of single-chain chimeric plasminogen activators consisting of a single-chain Fv fragment of a fibrin-specific antibody and single-chain urokinase.
Holvoet P; Laroche Y; Lijnen HR; Van Hoef B; Brouwers E; De Cock F; Lauwereys M; Gansemans Y; Collen D
Eur J Biochem; 1992 Dec; 210(3):945-52. PubMed ID: 1483477
[TBL] [Abstract][Full Text] [Related]
7. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor.
Cubellis MV; Andreasen P; Ragno P; Mayer M; Danø K; Blasi F
Proc Natl Acad Sci U S A; 1989 Jul; 86(13):4828-32. PubMed ID: 2544876
[TBL] [Abstract][Full Text] [Related]
8. Biochemical properties of recombinant single-chain urokinase-type plasminogen activator mutants with deletion of Asn2 through Phe157 and/or substitution of Cys279 with Ala.
Lijnen HR; Li XK; Nelles L; Hu MH; Collen D
Eur J Biochem; 1992 Apr; 205(2):701-9. PubMed ID: 1533368
[TBL] [Abstract][Full Text] [Related]
9. Cathepsin B efficiently activates the soluble and the tumor cell receptor-bound form of the proenzyme urokinase-type plasminogen activator (Pro-uPA).
Kobayashi H; Schmitt M; Goretzki L; Chucholowski N; Calvete J; Kramer M; Günzler WA; Jänicke F; Graeff H
J Biol Chem; 1991 Mar; 266(8):5147-52. PubMed ID: 1900515
[TBL] [Abstract][Full Text] [Related]
10. A transitional state of pro-urokinase that has a higher catalytic efficiency against glu-plasminogen than urokinase.
Liu JN; Pannell R; Gurewich V
J Biol Chem; 1992 Aug; 267(22):15289-92. PubMed ID: 1639775
[TBL] [Abstract][Full Text] [Related]
11. Occupancy of the cancer cell urokinase receptor (uPAR): effects of acid elution and exogenous uPA on cell surface urokinase (uPA).
Baker MS; Liang XM; Doe WF
Biochim Biophys Acta; 1992 Sep; 1117(2):143-52. PubMed ID: 1381963
[TBL] [Abstract][Full Text] [Related]
12. Biochemical and thrombolytic properties of a low molecular weight form (comprising Leu144 through Leu411) of recombinant single-chain urokinase-type plasminogen activator.
Lijnen HR; Nelles L; Holmes WE; Collen D
J Biol Chem; 1988 Apr; 263(12):5594-8. PubMed ID: 2965704
[TBL] [Abstract][Full Text] [Related]
13. Pro-urokinase: a study of its stability in plasma and of a mechanism for its selective fibrinolytic effect.
Pannell R; Gurewich V
Blood; 1986 May; 67(5):1215-23. PubMed ID: 3083889
[TBL] [Abstract][Full Text] [Related]
14. Neuronal plasminogen activators: cell surface binding sites and involvement in neurite outgrowth.
Pittman RN; Ivins JK; Buettner HM
J Neurosci; 1989 Dec; 9(12):4269-86. PubMed ID: 2512375
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activation by single-chain urokinase in functional isolation. A kinetic study.
Ellis V; Scully MF; Kakkar VV
J Biol Chem; 1987 Nov; 262(31):14998-5003. PubMed ID: 3667621
[TBL] [Abstract][Full Text] [Related]
16. Fragment E-2 from fibrin substantially enhances pro-urokinase-induced Glu-plasminogen activation. A kinetic study using the plasmin-resistant mutant pro-urokinase Ala-158-rpro-UK.
Liu JN; Gurewich V
Biochemistry; 1992 Jul; 31(27):6311-7. PubMed ID: 1385727
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a recombinant chimeric plasminogen activator composed of a fibrin fragment-D-dimer-specific humanized monoclonal antibody and a truncated single-chain urokinase.
Vandamme AM; Dewerchin M; Lijnen HR; Bernar H; Bulens F; Nelles L; Collen D
Eur J Biochem; 1992 Apr; 205(1):139-46. PubMed ID: 1313361
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activation with single-chain urokinase-type plasminogen activator (scu-PA). Studies with active site mutagenized plasminogen (Ser740----Ala) and plasmin-resistant scu-PA (Lys158----Glu).
Lijnen HR; Van Hoef B; Nelles L; Collen D
J Biol Chem; 1990 Mar; 265(9):5232-6. PubMed ID: 1969415
[TBL] [Abstract][Full Text] [Related]
19. Regulation of human squamous cell carcinoma plasma membrane associated urokinase plasminogen activator by epidermal growth factor.
Niedbala MJ; Bajetta S; Carbone R; Sartorelli AC
Cancer Commun; 1990; 2(9):317-24. PubMed ID: 2169831
[TBL] [Abstract][Full Text] [Related]
20. Biochemical properties of recombinant mutants of nonglycosylated single chain urokinase-type plasminogen activator.
Li XK; Lijnen HR; Nelles L; Hu MH; Collen D
Biochim Biophys Acta; 1992 Sep; 1159(1):37-43. PubMed ID: 1390910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]